Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$463.04 USD
-4.64 (-0.99%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $461.06 -1.98 (-0.43%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TMO 463.04 -4.64(-0.99%)
Will TMO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TMO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMO
Cigna Q2 Earnings Beat Estimates on Higher Specialty Volumes
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
TMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
ISRG's Gross Margin Falls on Product Transition and Trade Pressures
Company News for Jul 24, 2025
Thermo Fisher Q2 Earnings & Revenues Beat, Stock Up in Pre-Market
Other News for TMO
Putnam U.S. Large Cap Value Equity Concentrated SMA Q2 2025 Commentary
Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight
Fortune Brands Innovations Inc: A Key Focus in First Pacific Advisors' Latest 13F Filing
Franklin U.S. Focused Growth SMA Q2 2025 Commentary
Franklin DynaTech SMA Q2 2025 Commentary